咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Current focus of stem cell app... 收藏

Current focus of stem cell application in retinal repair

Current focus of stem cell application in retinal repair

作     者:Maria L Alonso-Alonso Girish Kumar Srivastava 

作者机构:Instituto Universitario de Oftalmobiologia Aplicada (IOBA) Universidad de Valladolid 47011 Valladolid Spain Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y Leon 47011 Valladolid Spain 

出 版 物:《World Journal of Stem Cells》 (世界干细胞杂志(英文版)(电子版))

年 卷 期:2015年第7卷第3期

页      面:641-648页

核心收录:

学科分类:1002[医学-临床医学] 100212[医学-眼科学] 10[医学] 

基  金:Partially supported by grants from Junta de Castilla y León,No.VA386A12-2 the Centro en Red de Medicina Regenerativa y Terapia Celular de la Junta de Castilla y León,47011 Valladolid,Spain a scholarship to Maria L Alonso-Alonso from the Consejería de Educación de Junta de Castilla y León and the Fondo Social Europeo 

主  题:Retina Adipose derived mesenchymal stemcells Embryonic stem cells Induced pluripotent stemcells Cell therapy 

摘      要:The relevance of retinal diseases, both in society s economy and in the quality of people s life who suffer with them, has made stem cell therapy an interesting topic forresearch. Embryonic stem cells(ESCs), induced pluripotent stem cells(i PSCs) and adipose derived mesenchymal stem cells(ADMSCs) are the focus in current endeavors as a source of different retinal cells, such as photoreceptors and retinal pigment epithelial cells. The aim is to apply them for cell replacement as an option for treating retinal diseases which so far are untreatable in their advanced stage. ESCs, despite the great potential for differentiation, have the dangerous risk of teratoma formation as well as ethical issues, which must be resolved before starting a clinical trial. i PSCs, like ESCs, are able to differentiate in to several types of retinal cells. However, the process to get them for personalized cell therapy has a high cost in terms of time and money. Researchers are working to resolve this since i PSCs seem to be a realistic option for treating retinal diseases. ADMSCs have the advantage that the procedures to obtain them are easier. Despite advancements in stem cell application, there are still several challenges that need to be overcome before transferring the research results to clinical application. This paper reviews recent research achievements of the applications of these three types of stem cells as well as clinical trials currently based on them.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分